Merck & Co., Inc. (MRK) Projects 21% Upside with $140 Price Target as Keytruda and New Vaccines Drive Growth

By Yahoo! Finance | Sep 30, 2024 at 04:58 AM EST

The article discusses Merck & Co., Inc. in the context of the best healthcare stocks favored by hedge funds. It highlights the growth potential of the healthcare sector amid economic challenges and provides insights into Merck's performance and investment outlook.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.